基本信息
浏览量:4
职业迁徙
个人简介
Dr. Berinstein's lab develops molecular assays to monitor and prognosticate human lymphomas. Using real-time polymerase chain reaction (PCR), his lab has developed highly sensitive and reproducible assays to detect minimal residual disease, and is applying them to monitor patients undergoing standard therapies and experimental therapies, including stem cell transplants. His lab has also developed real-time PCR-based assays to assess for single-nucleotide polymorphisms (known as SNPs) of immunologically relevant genes to determine whether enhanced prognostic models can be developed for patients undergoing routine or experimental cancer therapies. High-throughput assays using multi-colour dyes and high-resolution melting-point methods are being used and further developed.
In addition, Dr. Berinstein has a longstanding interest in cancer immunotherapy and continues to develop novel vaccine and immunomodulator therapeutic approaches.
In addition, Dr. Berinstein has a longstanding interest in cancer immunotherapy and continues to develop novel vaccine and immunomodulator therapeutic approaches.
研究兴趣
论文共 47 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
引用0浏览0WOS引用
0
0
BLOOD (2023): 3037
Sila Usta, Alexandra Misura,Kim Roos,Iran Rashedi,Irina Amitai,Yidi Jiang,Kathryn Mangoff,Gail Klein,Nicholas Allen Forward,Douglas A. Stewart,Joy Mangel,George A. Tomlinson,
Blood (2023): 6124
European Journal of Haematologyno. 2 (2023): 191-200
引用0浏览0引用
0
0
Hematological Oncologyno. 3 (2018): 525-532
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn